[PTGX] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
04-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 60.03%
YoY- 52.69%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 2,265 6,189 5,650 13,114 6,217 3,647 2,719 -11.47%
PBT -30,842 -23,998 -18,886 -7,763 -18,292 -19,904 -16,645 50.91%
Tax -57 -79 -1,305 -40 1,129 176 856 -
NP -30,842 -23,998 -18,886 -7,763 -19,421 -20,080 -17,501 45.94%
Tax Rate - - - - - - - -
Total Cost 33,107 30,187 24,536 20,877 25,638 23,727 20,220 38.95%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -1,361.68 -387.75 -334.27 -59.20 -312.39 -550.59 -643.66 64.87%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.69 -0.54 -0.48 -0.21 -0.59 -0.72 -0.63 6.25%
EPS Diluted -0.69 -0.54 -0.48 -0.21 -0.59 -0.72 -0.63 6.25%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.